Yaz and Yasmin News

Ortho Evra users who switch to Yaz or Yasmin may face side effects risk

Ortho Evra users who may have switched or are considering switching from the birth control patch to Yaz and Yasmin—or their generic equivalent, Ocella—may be surprised to learn of recent studies which have found an increased risk of blood clots compared to other birth control brands. Many Ortho Evra patients stopped using the patch after reports emerged that it could increase their risk of blood clots or other side effects. More »

New Yaz, Yasmin Warnings May Understate Blood Clots Risk

Yaz and Yasmin side effects website offers information to birth control users

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Yasmin Yaz Side Effects Lawyers. The site will serve as a news and information resource concerning the birth control pills Yaz, Yasmin and Ocella, which have been linked to an increased risk of blood clots, gallbladder disease and other side effects. More »

Six Yaz and Yasmin lawsuits filed in PA

Six women have filed lawsuits in Pittsburgh against the manufacturer of the birth control pills Yaz and Yasmin. The lawsuits against Bayer Corp. allege that Yaz and Yasmin are unsafe and may cause potentially fatal side effects. More than 150 Yaz or Yasmin lawsuits have been filed in the United States so far. More »

Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking Yaz or Yasmin

The law firm of Hissey Kientz, LLP is warning all women using the birth control pills Yaz or Yasmin that they may face an increased risk of blood clots, heart attack, stroke, pulmonary embolism, deep vein thrombosis and other significant side effects as a result of the defective design of these products. Women taking Yaz and Yasmin are twice as likely to develop blood clots compared with other forms of birth control, according to two studies published in the British Medical Journal. More »

Chicago woman files Yaz lawsuit over gallbladder injuries

A Chicago woman has filed a lawsuit against the manufacturers of the birth control pills Yaz alleging that they caused her to develop gallstones. Yaz and another popular form of birth control, Yasmin, contain a form of the hormone progestin called drospirenone. More »

FDA warns of quality control issues at YAZ, Yasmin factory

The Food and Drug Administration has sent a warning letter to drugmaker Bayer over quality control problems related to its birth control products, Yasmin and YAZ. FDA officials uncovered quality control problems at Bayer’s Berghamen, Germany plant during an inspection conducted there in March 2009. More »

Study finds increased blood clots risk with YAZ and Yasmin

A new study in the British Medical Journal has found that patients taking the birth control pills Yasmin, YAZ and Ocella may face an increased risk of blood clots and pulmonary embolism. The study also found an increased risk of side effects for users of Yasmin and YAZ compared with other types of birth control pills. More »

Bayer begins running ads to correct “misleading” Yaz information

Bayer Pharmaceuticals has launched a $20 million ad campaign for the birth control pill Yaz to previous marketing that the Food and Drug Administration labeled “misleading.” The new campaign is designed to alert women of the side effects of taking Yaz and to correct information from the previous ads, which overstated the health benefits of the drug. More »

FDA tells Bayer to pull misleading TV ads for YAZ

The Food and Drug Administration’s Division of Drug Marketing, Advertising, and Communications (DDMAC) has sent a warning letter to drugmaker Bayer about misleading TV advertisements for the company’s birth control pill YAZ. The warning letter states that the ads exaggerate the effectiveness of YAZ, downplay the serious side effects that have been linked to the birth control pills and convey the impression that they can be used to treat conditions for which they were not approved by the FDA. More »